# Dexmedetomidine vs Fentanyl on Time to Extubation in Patients Undergoing Laparoscopic Sleeve Gastrectomy

> **NCT06052111** · NA · COMPLETED · sponsor: **Helwan University** · enrollment: 64 (actual)

## Conditions studied

- Dexmedetomidine
- Fentanyl
- Time to Extubation
- Morbid Obesity
- Laparoscopic Sleeve Gastrectomy

## Interventions

- **DRUG:** Group F (fentanyl group)
- **DRUG:** Group D (dexmedetomidine group)

## Key facts

- **NCT ID:** NCT06052111
- **Lead sponsor:** Helwan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-15
- **Primary completion:** 2023-05-15
- **Final completion:** 2023-05-15
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2023-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06052111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06052111, "Dexmedetomidine vs Fentanyl on Time to Extubation in Patients Undergoing Laparoscopic Sleeve Gastrectomy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06052111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*